SMMT insider trading
NasdaqGM HealthcareSummit Therapeutics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Summit Therapeutics Inc.
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.
Company website: www.smmttx.com
SMMT insider activity at a glance
FilingIQ has scored 83 insider transactions for SMMT since Nov 6, 2020. The most recent filing in our index is dated Jun 4, 2026.
Across the full history, 38 open-market purchases
and 5 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SMMT insider trades is 67.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest SMMT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SMMT?
- FilingIQ tracks 83 Form 4 insider transactions for SMMT (Summit Therapeutics Inc.), covering filings from Nov 6, 2020 onwards. 4 of those were filed in the last 90 days.
- Are SMMT insiders net buyers or net sellers?
- Across the full Form 4 history for SMMT, 38 transactions (46%) were open-market purchases and 5 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SMMT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is SMMT in?
- Summit Therapeutics Inc. (SMMT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $13.91B.
Methodology & sources
Every SMMT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.